-
-
-
-
-
-
-
Edgewise Therapeutics (EWTX) PT Raised to $59; RBC Capital: 'We would be buyers on weakness'
-
-
-
-
-
-
-
Edgewise Therapeutics (EWTX) PT Raised to $52 at Wedbush
-
-
-
-
-
-
-
Raymond James: 'we continue to see a highly attractive long-term risk/reward skew for EWTX'
-
-
-
-
-
-
-
Truist Reiterates Buy Rating on Edgewise Therapeutics (EWTX)
-
-
-
-
-
-
-
Raymond James Starts Edgewise Therapeutics (EWTX) at Strong Buy
-
-
-
-
-
-
-
Edgewise Therapeutics, Inc. (EWTX) Reports In-Line Q1 EPS
-
-
-
-
-
-
-
Truist Securities Reiterates Buy Rating on Edgewise Therapeutics (EWTX), PT $50
-
465,842 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

